Chikungunya - Pipeline Review, H2 2015

1
Chikungunya - Pipeline Review, H2 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Scope
• The report provides a snapshot of the global
  therapeutic landscape of Chikungunya
• The report reviews key pipeline products under
  drug profile section which includes, product
  description, MoA and RD brief, licensing and
  collaboration details other developmental
  activities
• The report reviews key players involved in the
  therapeutics development for Chikungunya and
  enlists all their major and minor projects
• The report summarizes all the dormant and
  discontinued pipeline projects
• A review of the Chikungunya products under
  development by companies and universities/research
  institutes based on information derived from
  company and industry-specific sources
• Pipeline products coverage based on various
  stages of development ranging from
  pre-registration till discovery and undisclosed
  stages
• A detailed assessment of monotherapy and
  combination therapy pipeline projects
• Coverage of the Chikungunya pipeline on the basis
  of target, MoA, route of administration and
  molecule type
• Latest news and deals relating related to
  pipeline products
• Read More At http//www.researchbeam.com/chikung
  unya-pipeline-review-h2-2015-market

3


Table of Content
List of Figures Number of Products under
Development for Chikungunya, H2 2015 10 Number of
Products under Development for Chikungunya -
Comparative Analysis, H2 2015 11 Number of
Products under Development by Companies, H2 2015
12 Number of Products under Investigation by
Universities/Institutes, H2 2015 15 Comparative
Analysis by Clinical Stage Development, H2 2015
16 Comparative Analysis by Early Stage Products,
H2 2015 17 Assessment by Monotherapy Products, H2
2015 36 Number of Products by Top 10 Targets, H2
2015 37 Number of Products by Stage and Top 10
Targets, H2 2015 37 Number of Products by Top 10
Mechanism of Actions, H2 2015 39 Number of
Products by Stage and Top 10 Mechanism of
Actions, H2 2015 39 Number of Products by Routes
of Administration, H2 2015 41 Number of Products
by Stage and Routes of Administration, H2 2015
41 Number of Products by Top 10 Molecule Types,
H2 2015 43 Number of Products by Stage and Top 10
Molecule Types, H2 2015 43
4


Report Overview
Reasons to buy Provides strategically
significant competitor information, analysis, and
insights to formulate effective RD development
strategies Identify emerging players with
potentially strong product portfolio and create
effective counter-strategies to gain competitive
advantage Develop strategic initiatives by
understanding the focus areas of leading
companies Identify and understand important and
diverse types of therapeutics under development
for Chikungunya Plan mergers and acquisitions
effectively by identifying key players of the
most promising pipeline Devise corrective
measures for pipeline projects by understanding
Chikungunya pipeline depth and focus of
Indication therapeutics Develop and design
in-licensing and out-licensing strategies by
identifying prospective partners with the most
attractive projects to enhance and expand
business potential and Scope Modify the
therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove
them from pipeline Enquire At
http//www.researchbeam.com/chikungunya-pipeline-r
eview-h2-2015-market/enquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/chikungunya-pipeline-r
eview-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com